Julie K. Casteel, Chief Sales/Marketing Officer of IBEX Ltd, filed a Form 4 on November 10, 2026, disclosing the sale of 11,677 common shares at a weighted average price of $50.7156 per share.
Key Highlights
- Reporting person: Julie K. Casteel, identified as Chief Sales/Marketing Officer of IBEX Ltd (NASDAQ:IBEX)
- Transaction: Disposition of 11,677 common shares on November 10, 2026, with transaction code "S" (sale)
- Weighted average price: $50.7156 per share, executed across multiple trades ranging from $50.32 to $51.22
- Remaining holdings: 100,594 common shares beneficially owned directly following the transaction
- Filing agent: Lisa Lenstrohm, Attorney-in-Fact, signed on behalf of the reporting person on November 10, 2026
- No derivative securities: No transactions in derivative securities were reported in Table II
Casteel's November 2026 Share Sale: Transaction Details and Remaining Position
According to the Form 4 filing, Julie K. Casteel, serving as Chief Sales/Marketing Officer of IBEX Ltd, disposed of 11,677 common shares on November 10, 2026. The shares were sold at a weighted average price of $50.7156, with individual trades executed at prices ranging from $50.32 to $51.22, as noted in the filing's explanation of responses. The filing states that the reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the issuer, any security holder, or SEC staff.
Following the reported transaction, the filing discloses that Casteel directly beneficially owns 100,594 common shares of IBEX Ltd. The ownership is listed as direct, with no indirect beneficial ownership reported. Table II of the filing, covering derivative securities such as options or warrants, reflects no transactions or holdings for this reporting period.
The Form 4 was filed on November 10, 2026, the same date as the earliest reported transaction. Lisa Lenstrohm, identified as Attorney-in-Fact, signed the filing on that date on behalf of Casteel. No amendment date is indicated, meaning this is an original filing and not a revision of a prior submission.
What Was Disclosed
The filing reports a single open-market sale of 11,677 IBEX Ltd common shares by Chief Sales/Marketing Officer Julie K. Casteel on November 10, 2026, at a weighted average of $50.7156, leaving her with a directly held position of 100,594 shares.




Please wait processing your request...